Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Polak

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Database : the Journal of Biological Databases and Curation|July 25, 2024
Data set of fraction unbound values in the in vitro incubations for metabolic studies for better prediction of human clearanceLaura Krumpholz, Aleksandra Klimczyk, Wiktoria Bieniek, et al.
Pharmaceutics|October 3, 2020
Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special PopulationsSantosh Kumar Puttrevu, Sumit Arora, Sebastian Polak, et al.
Folia Medica Cracoviensia|February 12, 2016
How in vitro influences in silico utilized for the prediction of in vivo - pilot study of the drug-induced pro-arrhythmic potency predictionBogna Badyra, Bartosz Lisowski, Sebastian Polak, et al.
Journal of Applied Toxicology : JAT|January 7, 2015
Enhanced QSAR models for drug-triggered inhibition of the main cardiac ion currentsBarbara Wiśniowska, Aleksander Mendyk, Jakub Szlęk, et al.
Journal of Applied Toxicology : JAT|July 5, 2012
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessmentBarbara Wiśniowska, Aleksander Mendyk, Kamil Fijorek, et al.
Toxicology Mechanisms and Methods|November 5, 2016
Early assessment of proarrhythmic risk of drugs using the in vitro data and single-cell-based in silico models: proof of conceptMitra Abbasi, Ben G Small, Nikunjkumar Patel, et al.
Drug Discovery Today|August 4, 2023
3D printing combined with biopredictive dissolution and PBPK/PD modeling optimization and personalization of pharmacotherapy: Are we there yet?Gabriela Wyszogrodzka-Gaweł, Olha Shuklinova, Bartek Lisowski, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 18, 2008
Analysis of non-hospital antibacterial pharmacotherapy in PolandDominik Dziurda, Sebastian Polak, Agnieszka Skowron, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2013
Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: a case study using the BCS/BDDCS Class II drug nifedipineNikunjkumar Patel, Sebastian Polak, Masoud Jamei, et al.
Acta Poloniae Pharmaceutica|July 24, 2008
Antibacterial drug prescription for outpatients: age, seasonal and pulmonary disease dependencyDominik R Dziurda, Sebastian Polak, Agnieszka Skowron, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Database : the Journal of Biological Databases and Curation|July 25, 2024
Data set of fraction unbound values in the in vitro incubations for metabolic studies for better prediction of human clearanceLaura Krumpholz, Aleksandra Klimczyk, Wiktoria Bieniek, et al.
Pharmaceutics|October 3, 2020
Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special PopulationsSantosh Kumar Puttrevu, Sumit Arora, Sebastian Polak, et al.
Folia Medica Cracoviensia|February 12, 2016
How in vitro influences in silico utilized for the prediction of in vivo - pilot study of the drug-induced pro-arrhythmic potency predictionBogna Badyra, Bartosz Lisowski, Sebastian Polak, et al.
Journal of Applied Toxicology : JAT|January 7, 2015
Enhanced QSAR models for drug-triggered inhibition of the main cardiac ion currentsBarbara Wiśniowska, Aleksander Mendyk, Jakub Szlęk, et al.
Journal of Applied Toxicology : JAT|July 5, 2012
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessmentBarbara Wiśniowska, Aleksander Mendyk, Kamil Fijorek, et al.
Toxicology Mechanisms and Methods|November 5, 2016
Early assessment of proarrhythmic risk of drugs using the in vitro data and single-cell-based in silico models: proof of conceptMitra Abbasi, Ben G Small, Nikunjkumar Patel, et al.
Drug Discovery Today|August 4, 2023
3D printing combined with biopredictive dissolution and PBPK/PD modeling optimization and personalization of pharmacotherapy: Are we there yet?Gabriela Wyszogrodzka-Gaweł, Olha Shuklinova, Bartek Lisowski, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 18, 2008
Analysis of non-hospital antibacterial pharmacotherapy in PolandDominik Dziurda, Sebastian Polak, Agnieszka Skowron, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2013
Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: a case study using the BCS/BDDCS Class II drug nifedipineNikunjkumar Patel, Sebastian Polak, Masoud Jamei, et al.
Acta Poloniae Pharmaceutica|July 24, 2008
Antibacterial drug prescription for outpatients: age, seasonal and pulmonary disease dependencyDominik R Dziurda, Sebastian Polak, Agnieszka Skowron, et al.
Pageof 11